glp-1 dementia study drug slows alzheimer's cognitive decline by 18% Repurposing glucagon-like peptide-1 receptor agonists

Other potential uses: addiction, dementia, cancer Mike Haney: We mentioned before some of the other sort of non-weight benefits that we're seeing with this

However, despite improvements in OSA-related symptoms and hypertension, PAP has not demonstrated a benefit on composite cardiovascular endpoints in randomized controlled trials for primary [23] or secondary cardiovascular prevention [24,25,26]

In the absence of effective oral supplements, people have turned to glutathione precursors , compounds that stimulate the bodys own natural production of glutathione, such as whey protein and NAC (n-acetyl-cysteine)

McCall McPhereson: I love that

M., de Oliveira, G